Theranos, the biotech company notorious for fraudulent practices including faked test results and revenue, once achieved a $10 billion valuation despite having no real revenue. Recently, a Theranos-themed memecoin launched on the Solana blockchain has generated $381,000 in earnings and attracted over 300 new holders, reflecting ongoing interest despite the original company's controversies. The memecoin’s valuation is humorously compared to Theranos's inflated $9 billion valuation. Industry observers note that many blockchain projects with unproven performance metrics are expected to fail, while only those with genuine adoption and technology will succeed.